MARAVAI LIFESCIENCES HOLDINGS, INC.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
MRVI$7.86-2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except par value)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $216,890 | $322,399 |
| Accounts receivable, net | 25,498 | 38,520 |
| Inventory | 40,495 | 50,082 |
| Prepaid expenses and other current assets | 13,368 | 18,145 |
| Total current assets | 296,251 | 429,146 |
| Property and equipment, net | 151,479 | 164,474 |
| Goodwill | 129,429 | 159,878 |
| Intangible assets, net | 151,543 | 194,957 |
| Other assets | 41,875 | 59,789 |
| Total assets | $770,577 | $1,008,244 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $2,910 | $11,957 |
| Accrued expenses and other current liabilities | 36,567 | 39,574 |
| Current portion of long-term debt | 5,440 | 5,440 |
| Total current liabilities | 44,917 | 56,971 |
| Long-term debt, less current portion | 286,331 | 290,492 |
| Finance lease liabilities, less current portion | 30,141 | 31,106 |
| Other long-term liabilities | 36,477 | 52,466 |
| Total liabilities | 397,866 | 431,035 |
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity: | ||
| Class A common stock, $0.01 par value - 500,000 shares authorized; 145,324 and 141,976 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 1,453 | 1,420 |
| Class B common stock, $0.01 par value - 256,856 shares authorized; 110,684 shares issued and outstanding as of December 31, 2025 and 2024 | 1,107 | 1,107 |
| Additional paid-in capital | 199,177 | 181,874 |
| Retained earnings | 10,118 | 140,891 |
| Accumulated other comprehensive income | 524 | — |
| Total stockholders’ equity attributable to Maravai LifeSciences Holdings, Inc. | 212,379 | 325,292 |
| Non-controlling interest | 160,332 | 251,917 |
| Total stockholders’ equity | 372,711 | 577,209 |
| Total liabilities and stockholders’ equity | $770,577 | $1,008,244 |
The accompanying notes are an integral part of these consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.